BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10925538)

  • 21. Screening for primary aldosteronism.
    Schirpenbach C; Reincke M
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):369-84. PubMed ID: 16980200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F; Mattarello MJ; Albiger NM
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary hyperaldosteronism caused by monolateral adrenal hyperplasia].
    Angelini L; Bezzi M; Chiarot M; Coppola M; Eleuteri E; Martone N; Ferri C; Carlomagno A; Balsano F
    Minerva Chir; 1995; 50(1-2):131-7. PubMed ID: 7617250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathological and clinical studies on primary aldosteronism].
    Ozaki O; Kobayashi K; Notsu T; Maruyma S; Noritake S; Hirai K; Sageshima M; Mori T
    Nihon Geka Gakkai Zasshi; 1983 Mar; 84(3):256-62. PubMed ID: 6674796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on multiple aldosterone-producing adenomas].
    Yu XY; Kong CZ; Li ZH; Sun ZX; Li ZL; Bi JB; Gong DX
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1701-3. PubMed ID: 18476531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies.
    Radin DR; Manoogian C; Nadler JL
    AJR Am J Roentgenol; 1992 Mar; 158(3):553-7. PubMed ID: 1738993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of adrenal incidentaloma in patients with a history of malignancy.
    Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
    Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients.
    Rossi GP; Ganzaroli C; Miotto D; De Toni R; Palumbo G; Feltrin GP; Mantero F; Pessina AC
    J Hypertens; 2006 Feb; 24(2):371-9. PubMed ID: 16508586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adrenal vein catheterization in primary hyperaldosteronism: aid in surgical decision making?].
    Nascimbeni L; Lyonnet D; Vincent M; Lantelme P; Gouton M; Froment A; Ecochard R; Claustrat B; Milon H
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):874-8. PubMed ID: 11575222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine arterial hypertension: diagnostic approach in clinical practice.
    Mazza A; Zamboni S; Armigliato M; Zennaro R; Cuppini S; Rempelou P; Rubello D; Pessina AC
    Minerva Endocrinol; 2008 Jun; 33(2):127-46. PubMed ID: 18272953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
    Hennings J; Hellman P; Ahlström H; Sundin A
    Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative selenium-75-cholesterol imaging and computed tomography of the adrenal glands in Conn's syndrome.
    Miller JL; Smith JA; Mervis B
    S Afr Med J; 1982 Oct; 62(19):693-5. PubMed ID: 7135126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Computerized tomography and nuclear magnetic resonance tomography in adrenal gland diseases].
    Galanski M; Peters PE
    Bildgebung; 1987-1989; 56(4):147-55. PubMed ID: 3078252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI.
    Lumachi F; Marzola MC; Zucchetta P; Tregnaghi A; Cecchin D; Favia G; Bui F
    Nucl Med Commun; 2003 Jun; 24(6):683-8. PubMed ID: 12766605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia.
    Novitsky YW; Kercher KW; Rosen MJ; Cobb WS; Jyothinagaram S; Heniford BT
    Surgery; 2005 Dec; 138(6):1009-16; discussion 1016-7. PubMed ID: 16360385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal lesions with heterogeneous suppression on chemical shift imaging: clinical implications.
    Gabriel H; Pizzitola V; McComb EN; Wiley E; Miller FH
    J Magn Reson Imaging; 2004 Mar; 19(3):308-16. PubMed ID: 14994299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Morphology of the adrenal gland in primary hyperaldosteronism].
    Sigg C; Schweizer-Cagianut M; Hedinger C
    Schweiz Med Wochenschr; 1983 Mar; 113(10):357-67. PubMed ID: 6844895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes.
    Mulatero P; Bertello C; Rossato D; Mengozzi G; Milan A; Garrone C; Giraudo G; Passarino G; Garabello D; Verhovez A; Rabbia F; Veglio F
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1366-71. PubMed ID: 18198224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging of the adrenal glands: a comparison with computed tomography.
    Schultz CL; Haaga JR; Fletcher BD; Alfidi RJ; Schultz MA
    AJR Am J Roentgenol; 1984 Dec; 143(6):1235-40. PubMed ID: 6333793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.